Structures by: Abadleh M.
Total: 4
4-[5-(4-Fluorophenyl)-3-isopropylisoxazol-4-yl]pyridin-2(1H)-one
C17H15FN2O2
Acta Crystallographica Section E (2007) 63, 3 o1423-o1425
a=14.6895(7)Å b=7.3663(2)Å c=14.2056(6)Å
α=90.00° β=100.266(5)° γ=90.00°
3,4-bis(4-fluorophenyl)-1,2,5-oxadiazole 2-oxide
C14H8F2N2O2
Acta Crystallographica Section E (2006) 62, 11 o4827-o4828
a=17.797(2)Å b=10.3032(7)Å c=14.2799(14)Å
α=90.00° β=111.251(10)° γ=90.00°
4-[5-(4-fluorophenyl)-3-isopropylisoxazol-4-yl]pyridine
C17H15FN2O
Acta Crystallographica Section E (2006) 62, 9 o3647-o3649
a=14.1426(10)Å b=11.8646(9)Å c=17.8516(13)Å
α=90.00° β=105.475(4)° γ=90.00°
4-[3-(4-fluorophenyl)-5-isopropylisoxazol-4-yl]pyridine
C17H15FN2O
Acta Crystallographica Section E (2006) 62, 9 o3707-o3709
a=15.490(2)Å b=11.4393(9)Å c=17.878(3)Å
α=90.00° β=110.838(7)° γ=90.00°